Evidence map›Paper›PMID 28918507›Full record

ArticleApoptosis : an international journal on programmed cell death2017

The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA.

Terri J Harford, Greg Kliment, Girish C Shukla, Crystal M Weyman

Open access · greenAbstract read
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Mitochondrial stress response and myogenic differentiation.Frontiers in cell and developmental biology · 2024
    Review
  5. Article
  6. Article
  7. Marek's Disease Virus (Frontiers in microbiology · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Terri J HarfordDepartment of Biological, Geological, and Environmental Sciences, Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH, 44115, USA.
Greg KlimentDepartment of Biological, Geological, and Environmental Sciences, Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH, 44115, USA.
Girish C ShuklaDepartment of Biological, Geological, and Environmental Sciences, Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH, 44115, USA.
Crystal M WeymanDepartment of Biological, Geological, and Environmental Sciences, Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH, 44115, USA. c.weyman@csuohio.edu.ORCID http://orcid.org/0000-0001-6384-7469
Cleveland State University · US

Funding

Molecular Regulation of Skeletal Myoblast ApoptosisR15AR053857 · NIAMS · CLEVELAND STATE UNIVERSITY · PI WEYMAN, CRYSTAL M · 2008 to 2009
$389k
National Institute of Arthritis and Musculoskeletal and Skin Diseases AR053857-S1NIAMS NIH HHS R15 AR053857
6 · The paper itself

Abstract

The muscle regulatory transcription factor MyoD is a master regulator of skeletal myoblast differentiation. We have previously reported that MyoD is also necessary for the elevated expression of the pro-apoptotic Bcl2 family member PUMA, and the ensuing apoptosis, that occurs in a subset of myoblasts induced to differentiate. Herein, we report the identification of a functional MyoD binding site within the extended PUMA promoter. In silico analysis of the murine PUMA extended promoter revealed three potential MyoD binding sites within 2 kb of the transcription start site. Expression from a luciferase reporter construct containing this 2 kb fragment was enhanced by activation of MyoD in both myoblasts and fibroblasts and diminished by silencing of MyoD in myoblasts. Experiments utilizing truncated versions of this promoter region revealed that the potential binding site at position - 857 was necessary for expression. Chromatin immunoprecipitation (ChIP) analysis confirmed binding of MyoD to the DNA region encompassing position - 857. The increase in MyoD binding to the PUMA promoter as a consequence of culture in differentiation media (DM) was comparable to the increase in MyoD binding at the myogenin promoter and was diminished in myoblasts silenced for MyoD expression. Finally, ChIP analysis using an antibody specific for the transcription factor p53 demonstrated that, in myoblasts silenced for MyoD expression, p53 binding to the PUMA promoter was diminished in response to culture in DM. These data indicate that MyoD plays a direct role in regulating PUMA expression and reveal functional consequences of MyoD expression on p53 mediated transcription of PUMA.

Indexed as

AnimalsApoptosis Regulatory ProteinsBinding SitesCell DifferentiationCell LineCulture MediaFibroblastsGene Expression RegulationGene SilencingMiceMicroRNAsMyoblastsMyoD ProteinMyogeninPromoter Regions, GeneticProtein BindingApoptosis Regulatory ProteinsCulture MediaMicroRNAsMyoD1 myogenic differentiation proteinMyoD ProteinMyogeninMyog protein, mousePUMA protein, mouseTumor Suppressor Protein p53Tumor Suppressor ProteinsApoptosisMyoDP53PUMA

Identifiers

PMID28918507
PMCPMC5693709
OpenAlexW2754817651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.